Gossamer Bio
GOSS
GOSS
120 hedge funds and large institutions have $225M invested in Gossamer Bio in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 35 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
65% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 60
78% less capital invested
Capital invested by funds: $1.02B → $225M (-$796M)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
Holders
120
Holding in Top 10
–
Calls
$857K
Puts
$857K
Top Buyers
| 1 | +$52.2M | |
| 2 | +$7.15M | |
| 3 | +$5.83M | |
| 4 |
Rafferty Asset Management
New York
|
+$5.52M |
| 5 |
Morgan Stanley
New York
|
+$4.24M |
Top Sellers
| 1 | -$49.8M | |
| 2 | -$38.3M | |
| 3 | -$20.9M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$18M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$17.4M |